These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3933664)

  • 21. Prostanoids cytoprotection for maintaining remission in ulcerative colitis. Failure of 15(R), 15-methylprostaglandin E2.
    Goldin E; Rachmilewitz D
    Dig Dis Sci; 1983 Sep; 28(9):807-11. PubMed ID: 6136395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evaluation of arbaprostil at multiple doses for the treatment of acute duodenal ulcer: a randomized double-blind placebo-controlled international trial.
    Euler AR; Krawiec J; Odes H; Gilat T; Garcia L; Rachmilewitz D; Gabryelewicz A; Gibinski K; Bass D; Barbara L
    Am J Gastroenterol; 1990 Feb; 85(2):145-9. PubMed ID: 2405642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of 15(R)-15-methyl prostaglandin E2 (Arbacet) on the healing of aspirin or nonsteroidal antiinflammatory drug-induced gastric mucosal lesions: an endoscopic study.
    Jaszewski R; Crane SA
    Am J Gastroenterol; 1987 Dec; 82(12):1271-4. PubMed ID: 3318402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer].
    Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D
    Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug treatment of bleeding peptic ulcers].
    Havelund T; Laursen LS; Lauritsen K
    Ugeskr Laeger; 1987 Mar; 149(11):707-10. PubMed ID: 2883748
    [No Abstract]   [Full Text] [Related]  

  • 26. Somatostatin in peptic ulcer bleeding--results of a double-blind controlled trial.
    Galmiche JP; Cassigneul J; Faivre J; Tranvouez JL; Ouvry D; Colin R; Pascal JP; Klepping C
    Int J Clin Pharmacol Res; 1983; 3(5):379-87. PubMed ID: 6147315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the synthesized prostaglandin E2-analogue arbaprostil on gastric mucosal lesions in rats.
    Sugiyama S; Kawabe Y; Kuroiwa M; Goto H; Tsukamoto Y; Ozawa T
    Arzneimittelforschung; 1989 Dec; 39(12):1571-3. PubMed ID: 2624606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoprotective dose of prostaglandins.
    Wilson DE
    Gastroenterology; 1987 Aug; 93(2):434. PubMed ID: 3596177
    [No Abstract]   [Full Text] [Related]  

  • 29. Peptic ulcer disease, cytoprotection, and prostaglandins.
    Fiske SC
    Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
    [No Abstract]   [Full Text] [Related]  

  • 30. [Various problems on refractory peptic ulcers; progress of drug therapy and changes in the concept of peptic ulcer].
    Ishimori A; Kawamura T
    Nihon Rinsho; 1988 Jan; 46(1):146-51. PubMed ID: 3373747
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma levels of the prodrug, arbaprostil, [(15R)-15-methylprostaglandin E2], and its active, antiulcer (15S) epimer in humans after single dose oral administration.
    Cox JW; Bothwell WM; Pullen RH; Wynalda MA; Fitzpatrick FA; VanderLugt JT
    J Pharm Sci; 1986 Nov; 75(11):1107-12. PubMed ID: 3820107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of peptic ulcer with cytoprotective substances].
    Fortunat W
    Wien Med Wochenschr; 1983; 133(4-5):94-8. PubMed ID: 6407215
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prostaglandin analogs for the treatment of peptic ulcer].
    Mutoh H
    Nihon Rinsho; 1984 Jan; 42(1):125-9. PubMed ID: 6371306
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomised trial of fibrin glue versus polidocanol for bleeding peptic ulcer.
    Fullarton G; Galloway D
    Lancet; 1997 Nov; 350(9088):1397; author reply 1398. PubMed ID: 9365471
    [No Abstract]   [Full Text] [Related]  

  • 35. [Somatostatin and cimetidine in peptic ulcer hemorrhage. A randomized controlled study].
    Kayasseh L; Gyr K; Keller U; Stalder GA
    Z Gastroenterol; 1980 Jun; 18(6):342-3. PubMed ID: 6106322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arbaprostil (15(R)-15-methyl PGE2): lack of effect on theophylline metabolism.
    Reele SB; Euler A; McEvers J; Metzler C
    Br J Clin Pharmacol; 1986 Feb; 21(2):239-41. PubMed ID: 3954940
    [No Abstract]   [Full Text] [Related]  

  • 37. Acid inhibition and peptic ulcer bleeding.
    Štimac D; Franjić N; Krznarić Ž
    Dig Dis; 2011; 29(5):494-8. PubMed ID: 22095017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption, tissue distribution, and excretion of 3H-labeled arbaprostil in the male rat.
    Sinha AJ; Shaw SR; Thornburgh BA
    Eur J Drug Metab Pharmacokinet; 1985; 10(2):171-7. PubMed ID: 4043145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised trial of fibrin glue versus polidocanol for bleeding peptic ulcer.
    Albillos A; Calleja JL
    Lancet; 1997 Nov; 350(9088):1397-8. PubMed ID: 9365472
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation of plasma components by double antibody precipitation and filtration: application to the chromatographic determination of arbaprostil ([15R]-15-methylprostaglandin E2).
    Cox JW; Pullen RH; Royer ME
    Anal Chem; 1985 Oct; 57(12):2365-9. PubMed ID: 4061844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.